DRUG COMPOSITION

PURPOSE:To obtain a safe and uniform sustained-release drug composition of mucosa application type by gelatinizing a viscous emulsion comprising a combination of a specific fatty acid, benzyl alcohol, octyl dodecanol, etc., polyvinyl alcohol, cationic drug and water. CONSTITUTION:A uniform viscous e...

Full description

Saved in:
Bibliographic Details
Main Author ISHIKURA TOYOAKI
Format Patent
LanguageEnglish
Published 21.02.1991
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PURPOSE:To obtain a safe and uniform sustained-release drug composition of mucosa application type by gelatinizing a viscous emulsion comprising a combination of a specific fatty acid, benzyl alcohol, octyl dodecanol, etc., polyvinyl alcohol, cationic drug and water. CONSTITUTION:A uniform viscous emulsion comprising one or a combination of two or more selected from 10-20C fatty acids (e.g. isostearic acid, oleic acid, myristic acid or stearic acid), benzyl alcohol, octyl dodecanol and oleyl alcohol, polyvinyl alcohol, a cationic drug (e.g. pranoprofen, tiaramide chloride or fentanyl citrate) and water is packed into a shaping mold, frozen, thawed and gelatinized to give a drug composition.
Bibliography:Application Number: JP19890177715